Monday, September 1st, 2025
Stock Profile: NPCE
NPCE Logo

NeuroPace, Inc. (NPCE)

Market: NASD | Currency: USD

Address: 455 North Bernardo Avenue

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 Show more




📈 NeuroPace, Inc. Historical Chart






📊 Statistics





💰 Dividend History


No dividend history available.



📅 Earnings & EPS History for NeuroPace, Inc.


DateReported EPS
2025-11-11 (estimated upcoming)-
2025-08-12-0.26
2025-05-13-0.21
2025-03-04-0.18
2024-11-12-0.19
2024-08-13-0.26
2024-05-08-0.32
2024-03-05-0.23
2023-11-06-0.28
2023-08-08-0.36
2023-05-04-0.41
2023-03-02-0.45
2022-11-08-0.48
2022-08-11-0.52
2022-05-12-0.47
2022-03-10-0.44
2021-11-10-0.34
2021-08-12-0.48
2021-06-03-0.36




📰 Related News & Research


No related articles found for "neuropace inc".